LENICURA GmbH

About LENICURA

LENICURA GmbH is a medical technology company based in Wiesbaden. The company developed the lAight® therapy, a non-invasive medical device for the treatment of acne inversa (hidradenitis suppurativa), acute abscesses, and acne. At the turn of 2016/2017, lAight® was approved as the first medical device for the indication Acne inversa. In addition to therapy development, LENICURA provides services in the healthcare sector: supporting Innovation Fund projects of the G-BA from conception to evaluation, as well as acting as a management company for special care contracts under § 140a SGB V, including with AOK Hessen and AOK Bayern. The company is certified according to EN ISO 13485:2012+AC:2012 and supports doctors and patients with training and support in Germany, Austria, and Switzerland.

Site

Wiesbaden

Processes

Development of the lAight® therapy (non-invasive treatment of acne inversa, acute abscesses, and, Support for Innovation Fund projects of the G-BA (Conception, Application, Implementation,, Methodological Consulting & Scientific Planning (Study designs, Data collection, Evaluation), Project management and coordination, Network & strategic partnerships, Management company for special care contracts under § 140a SGB V, Enrollment of providers and insured persons, Billing of services with health insurance companies

Certificates

EN ISO 13485:2012+AC:2012, EN ISO 13485

Industries

Medical Technology / MedTech, Healthcare, Dermatology, Research / Study Provision

1. 01

   Research and Development

2. 02

   Clinical Studies

3. 03

   Certification and Approval

4. 04

   Sales and Doctor Training

5. 05

   Management of Special Care Contracts

6. 06

   Customer Support and Product Support

Locations

Wiesbaden

DE

Headquarters

Inside the production

Quality

LENICURA has been certified according to EN ISO 13485:2012+AC:2012 since May 2016. The company implements structured quality monitoring to ensure quality of care.

History

1. 2011

   Dr. Reinhard identifies technologies from aesthetic medical devices with potential for treating acne inversa; Dr. Andreas Hafner (University of Mainz) and Prof. Dr. Stefan Zirn are recruited for the research project

2. 2012

   Arend Poppner joins the team to develop a support concept for doctors and patients; LENICURA is founded

3. 2016

   LENICURA has been certified according to EN ISO 13485:2012+AC:2012 since May 2016

4. 2016

   First results of the NICE study (Mainz Dermatology Clinic) presented at the EADV Congress in Vienna

5. 2016/2017

   lAight® by LENICURA is approved as the first medical device for the indication Acne inversa

6. LENICURA is awarded the Hessian Founder's Award